CurrentRheuma
Get Weekly

Topic · page 17 of 17

Systemic sclerosis & Raynaud's

Limited and diffuse systemic sclerosis, skin, lung (interstitial lung disease), pulmonary arterial hypertension, heart, gut and kidney involvement in systemic sclerosis, digital ulcers, primary and secondary Raynaud's phenomenon, very early systemic sclerosis

Briefs 641–671 of 671 placed here, newest publication first

Briefs in Systemic sclerosis & Raynaud's

Newest publication first

  1. Scand J Rheumatol

    Therapy satisfaction and health literacy are key factors to improve medication adherence in systemic sclerosis

    Cross-sectional study

  2. Rheumatology (Oxford)

    Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial

    Secondary analysis

  3. Rheumatology (Oxford)

    Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database

    Cohort study

  4. Arthritis Care Res (Hoboken)

    Slow Colonic Transit in Systemic Sclerosis: An Objective Assessment of Risk Factors and Clinical Phenotype

    Cohort study

  5. Rheumatology (Oxford)

    Cardiac magnetic resonance imaging before and after therapeutic interventions for systemic sclerosis-associated myocarditis

    Cohort study

  6. Rheumatology (Oxford)

    Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients

    Cohort study

  7. Rheumatology (Oxford)

    Dendritic cells drive profibrotic inflammation and aberrant T cell polarization in systemic sclerosis

    Mechanistic study

  8. Rheumatology (Oxford)

    Longitudinal global transcriptomic profiling of preclinical systemic sclerosis reveals molecular changes associated with disease progression

    Cohort study

  9. Clin Exp Rheumatol

    Association of endothelial to mesenchymal transition and cellular senescence with fibrosis in skin biopsies of systemic sclerosis patients: a cross-sectional study

    Cross-sectional study

  10. Rheumatology (Oxford)

    A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trials

    Cohort study

  11. Arthritis Care Res (Hoboken)

    Physical Therapy in Systemic Sclerosis: The Patient Perspective

    Cross-sectional study

  12. Arthritis Care Res (Hoboken)

    Circulating CTRP9 Is Associated With Severity of Systemic Sclerosis–Associated Interstitial Lung Disease

    Cohort study

  13. Rheumatology (Oxford)

    Survival in Swedish patients with systemic sclerosis: a nationwide population-based matched cohort study

    Cohort study

  14. Rheumatology (Oxford)

    Mobilization with reduced cyclophosphamide for autologous stem cell transplantation is feasible in patients with systemic sclerosis

    Cohort study

  15. Rheumatology (Oxford)

    Human dermal fibroblast-derived exosomes induce macrophage activation in systemic sclerosis

    Mechanistic study

  16. Rheumatology (Oxford)

    Differences in symptom experience among patients with systemic sclerosis: a cluster analytic approach to identifying subgroups

    Cross-sectional study

  17. Rheumatology (Oxford)

    Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model

    Diagnostic or prognostic study

  18. Rheumatology (Oxford)

    A phase 2 trial investigating the effects of the angiotensin II type 2 receptor agonist C21 in systemic sclerosis-related Raynaud’s

    Randomized controlled trial

  19. Scand J Rheumatol

    Kinetics of response to iloprost evaluated by laser speckle contrast analysis in systemic sclerosis

    Cohort study

  20. Rheumatology (Oxford)

    FLT3 functional low-frequency variant rs76428106-C is associated with susceptibility to systemic sclerosis

    Case-control study

  21. Clin Exp Rheumatol

    Anti-Th/To antibodies in systemic sclerosis: analysis of long-term follow-up of pulmonary involvement, organ damage accrual and mortality in an Italian cohort with a case-control study

    Case-control study

  22. Rheumatology (Oxford)

    Autologous stem cell transplantation improves cardiopulmonary exercise testing outcomes in systemic sclerosis patients

    Cohort study

  23. Rheumatology (Oxford)

    Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort

    Cohort study

  24. Rheumatology (Oxford)

    Clinico–pathological phenotypes of systemic sclerosis–associated myopathy: analysis of a large multicentre cohort

    Cohort study

  25. Rheumatology (Oxford)

    Lung vascular changes as biomarkers of severity in systemic sclerosis–associated interstitial lung disease

    Cohort study

  26. Rheumatology (Oxford)

    DNA from macrophages induces fibrosis and vasculopathy through POLR3A/STING/type I interferon axis in systemic sclerosis

    Mechanistic study

  27. Rheumatology (Oxford)

    Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation

    Cohort study

  28. Rheumatology (Oxford)

    Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease

    Secondary analysis

  29. Rheumatology (Oxford)

    Evaluation of left cardiac chamber function with cardiac magnetic resonance and association with outcome in patients with systemic sclerosis

    Cohort study

  30. Scand J Rheumatol

    The validity of systemic sclerosis diagnoses in two university hospitals in Finland

    Diagnostic or prognostic study

  31. Rheumatology (Oxford)

    The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial

    Randomized controlled trial

All 671 Briefs in ExploreShowing Briefs 641–671 of 671, newest first